Profil
Nicholas Robbins-Cherry is currently the Chief Financial Officer, Director & Vice President at Ixaka Ltd. He previously worked as the Finance Director at CACI Ltd. from 2008 to 2013 and at The Marketing Practice (UK) Ltd. from 2013 to 2014.
In 2019, he briefly served as the Secretary at Biodexa Pharmaceuticals Plc.
Aktive Positionen von Nicholas Robbins-Cherry
| Unternehmen | Position | Beginn |
|---|---|---|
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Finanzdirektor/CFO | 01.10.2021 |
Ehemalige bekannte Positionen von Nicholas Robbins-Cherry
| Unternehmen | Position | Ende |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Finanzdirektor/CFO | 09.09.2019 |
The Marketing Practice (UK) Ltd.
The Marketing Practice (UK) Ltd. Advertising/Marketing ServicesCommercial Services Operates as a B2B marketing agency | Finanzdirektor/CFO | 01.01.2014 |
CACI Ltd.
CACI Ltd. Data Processing ServicesTechnology Services Provides data and technology solutions | Finanzdirektor/CFO | 01.01.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
CACI Ltd.
CACI Ltd. Data Processing ServicesTechnology Services Provides data and technology solutions | Technology Services |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
The Marketing Practice (UK) Ltd.
The Marketing Practice (UK) Ltd. Advertising/Marketing ServicesCommercial Services Operates as a B2B marketing agency | Commercial Services |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Health Technology |
















